Showing results (861-870 of 2,231) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|June 29, 2013
Preliminary study of the biodegradation and the correlation between in vitro and in vivo release of (32)P-chromic phosphate-poly(L-lactide) seedsJun Zhao, Guangtao Du, Yan Su, et al.Cancer Biotherapy & Radiopharmaceuticals|December 6, 2012
Patient-specific whole-body attenuation correction maps from a CT system for conjugate-view-based activity quantification: method development and evaluationKatarina Sjögreen Gleisner, Michael LjungbergCancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodiesRobert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinomaJisheng Liu, Weihua Sheng, Yufeng Xie, et al.Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitroEduardo Mansilla, Gustavo H Marin, Luis Nuñez, et al.Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Synthesis of a novel antiestrogen radioligand (99mTc-TOR-DTPA)Ayfer Yurt, Fazilet Zumrut B Muftuler, Perihan Unak, et al.Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Potential utility of radioprotective agents in the practice of nuclear medicineSeyed Jalal HosseinimehrCancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administrationAndres Forero, Ruby F Meredith, M B Khazaeli, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
In vitro characterization of 211 At-labeled antibody A33--a potential therapeutic agent against metastatic colorectal carcinomaYlva Almqvist, Anna Orlova, Anna Sjöström, et al.Pageof 224